Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

NCT00003869 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

NIH

Sponsor class

Conditions

Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: carboxyamidotriazole
OTHER: placebo
PROCEDURE: quality-of-life assessment
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)